| One in every two individuals born today will be diagnosed with cancer—a genetic disease—at some point during their lifetime. Nick Bellanca of Wamberg Genomic Advisors breaks down their flagship product, Cancer Guardian, as the burgeoning field of genomics becomes more closely intertwined to employee benefits offerings.
Read on. (link: https://leadersedgemagazine.com/articles/2019/03/genetic-benefit) |